Page last updated: 2024-11-05

triamterene and Cochlear Hearing Loss

triamterene has been researched along with Cochlear Hearing Loss in 2 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Research Excerpts

ExcerptRelevanceReference
"To describe the course of Meniere's disease with noninvasive treatment during the first few years after initial diagnosis."1.48Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine. ( Christov, F; Gluth, MB; Sbeih, F, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sbeih, F1
Christov, F1
Gluth, MB1
Milner, RM1
Meltzer, CR1
Brenman, AK1

Other Studies

2 other studies available for triamterene and Cochlear Hearing Loss

ArticleYear
Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine.
    The Annals of otology, rhinology, and laryngology, 2018, Volume: 127, Issue:5

    Topics: Audiometry, Pure-Tone; Auditory Threshold; Betahistine; Dexamethasone; Drug Combinations; Female; Fo

2018
Sudden hearing loss.
    The American journal of otology, 1982, Volume: 3, Issue:4

    Topics: Adult; Audiometry; Bed Rest; Dexamethasone; Drug Combinations; Hearing Loss, Sensorineural; Hearing

1982